Literature DB >> 3117460

HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro.

I Todd1, R Pujol-Borrell, B A Abdul-Karim, L J Hammond, M Feldmann, G F Bottazzo.   

Abstract

Human thyroid epithelial cells (thyrocytes) express HLA Class II molecules in autoimmune thyroid diseases (ATD). Normal thyrocytes do not express Class II, but can be induced to do so by culture with interferon-gamma (gamma-IFN). We have examined HLA-D subregion expression in sections and monolayers of thyroid by indirect immunofluorescence using appropriate monoclonal antibodies. The results indicate that, in ATD, the incidence and intensity of Class II subregion expression by thyrocytes varies between patients, and follows the pattern DR greater than DP greater than DQ. The same hierarchy is observed in cultured normal thyrocytes treated with gamma-IFN: strong induction of Class II, and of DP and DQ in particular, requires relatively high concentrations of gamma-IFN or additional factors such as thyroid stimulating hormone. These findings suggest that HLA-D subregion expression by thyrocytes in on-going ATD is determined by the levels of disease related factors in the affected tissue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117460      PMCID: PMC1542361     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; J M McNally; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.

Authors:  G Aichinger; H Fill; G Wick
Journal:  Lab Invest       Date:  1985-02       Impact factor: 5.662

3.  Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.

Authors:  T A Gonwa; L J Picker; H V Raff; S M Goyert; J Silver; J D Stobo
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

4.  Characterization of lymphoid cells in the thyroid of patients with Graves' disease.

Authors:  A Warford; S M McLachlan; A J Malcolm; E T Young; J R Farndon; B Rees Smith
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens.

Authors:  P G Natali; O Segatto; S Ferrone; R Tosi; G Corte
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

Authors:  T Collins; A J Korman; C T Wake; J M Boss; D J Kappes; W Fiers; K A Ault; M A Gimbrone; J L Strominger; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Syngeneic sensitization of mouse lymphocytes on monolayers of thyroid epithelial cells. V. The primary syngeneic sensitization is under I-A subregion control.

Authors:  J Salamero; J Charreire
Journal:  Eur J Immunol       Date:  1983-11       Impact factor: 5.532

8.  Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.

Authors:  T Hanafusa; R Pujol-Borrell; L Chiovato; R C Russell; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

9.  Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

Authors:  S Carrel; A Schmidt-Kessen; L Giuffrè
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

10.  Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis.

Authors:  G Ballardini; R Mirakian; F B Bianchi; E Pisi; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

View more
  4 in total

1.  Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells.

Authors:  R Q Zheng; E R Abney; C Q Chu; M Field; R N Maini; J R Lamb; M Feldmann
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

2.  Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells.

Authors:  I Todd; L J Hammond; R F James; M Feldmann; G F Bottazzo
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

Review 3.  [Recent aspects of the pathogenesis of endocrine autoimmune diseases in the human: what role does expression of class II HLA molecules in the endocrine target cell play?].

Authors:  U Deuss; M Buscema; G F Bottazzo; W Winkelmann
Journal:  Klin Wochenschr       Date:  1989-11-17

4.  Intercellular adhesion molecule-1 (ICAM-1) in Graves' disease: contrast between in vivo and in vitro results.

Authors:  A Ciampolillo; G Napolitano; R Mirakian; A Miyasaki; R Giorgino; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.